Nadine is an economist by training and is primarily interested in the methodology, processes, and outcomes of health technology assessment. She has experience applying both quantitative and qualitative research methods. Nadine leads the maintenance of OHE’s Medicines Tracker’, a database which records regulatory and HTA (NICE and SMC) information on new medicines.

Her current research interests centre around economic evaluation in health care; she has researched HTA methodological challenges faced by treatments for rare and ultrarare diseases, histologyindependent therapies, and gene therapies. Nadine also has experience conducting research into preferencebased measures, including the development of EQ5D ‘bolton’ items and assessing the appropriateness of the EORTC QLUC10D.